How the Anticipated Pluvicto Label Expansion Redefines Prostate Cancer Commercial Strategy
The strategic landscape of prostate cancer treatment is undergoing a massive shift as Novartis prepares for regulatory filings that could reshape targeted radiotherapy. The anticipated Pluvicto label expansion is poised…